A detailed history of Core Wealth Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Core Wealth Partners LLC holds 4,550 shares of BMY stock, worth $262,444. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,550
Holding current value
$262,444
% of portfolio
0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$39.66 - $51.75 $180,452 - $235,462
4,550 New
4,550 $235 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $171,679 - $203,292
2,507 New
2,507 $353 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Core Wealth Partners LLC Portfolio

Follow Core Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Wealth Partners LLC with notifications on news.